PropertyValue
?:abstract
  • From the Document: As serological testing for SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] advances, there are multiple issues that need to be addressed, from test quality to interpretation Unlike molecular tests for COVID-19 [coronavirus disease 2019] (e g , PCR [polymerase chain reaction]), antibody tests may be better suited for public health surveillance and vaccine development than for diagnosis The current antibody testing landscape is varied and clinically unverified, and these tests should not be used as the sole test for diagnostic decisions Further, until more evidence about protective immunity is available, serology results should not be used to make staffing decisions or decisions regarding the need for personal protective equipment The sections below outline the current state of antibody testing for SARS-CoV-2, along with research questions and additional testing and policy considerations This information will be updated regularly as new research, tests, and increased public health capacity become available COVID-19 (Disease);Health--Testing
is ?:annotates of
?:creator
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • IDSA COVID-19 Antibody Testing Primer
?:type
?:who_covidence_id
  • #740353
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/dx3afh8n>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/dx3afh8n>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all